AIT Therapeutics, Inc.
AIT Therapeutics, Inc. is listed today as Beyond Air, Inc.: market value, financials and filings are on its company page.
Funding rounds
1 counted as startup funding, 4 other private sales on record. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Sep 2024 | $21 M | Private placement after listing | $10 to $50 million | equity, options | SEC | |
| Jun 2023 | $1 M | Private placement after listing | Under $2 million | equity, options | SEC | |
| Jun 2019 | $8 M | Private placement after listing | $2 to $10 million | equity | SEC | |
| Feb 2018 | $10 M | No. 1 | $2 to $10 million | options | SEC | |
| Jan 2017 | $37 M | Issued in a merger or acquisition | $10 to $50 million | equity, options | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
AIT Therapeutics, Inc. chose not to state its revenue in its newest notice of a funding round (Oct 2024).
SEC Form D · Oct 2024
The industry group it chose in its notices: Pharmaceuticals.
SEC Form D · Oct 2024
That is all the official record says: AIT Therapeutics, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.
Products and services#
No products or services of AIT Therapeutics, Inc. are on record.
Investors#
No investor of AIT Therapeutics, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 1 round above had up to 58 investors.
Largest shareholders today
Institutions holding Beyond Air, Inc. shares, as of Sep 30, 2026.
- Armistice Capital, LLC$0 M6.18%
- Balyasny Asset Management L.P.$0 M4.27%
- Daytona Street Capital LLC$0 M1.06%
- HRT Financial LP$0 M0.76%
- Bleichroeder LP$0 M0.26%
- Vanguard Capital Management LLC$0 M0.19%
- Vanguard Fiduciary Trust Co$0 M0.09%
- UBS Group AG$0 M0.08%
- Tower Research Capital LLC (TRC)$0 M0.07%
- Jones Financial Companies Lllp$0 M0.06%
- BlackRock, Inc.$0 M0.06%
- Osaic Holdings, Inc.$0 M0.02%
- PFS Partners, LLC$0 M0.01%
- IFP Advisors, Inc$0 M0.00%
- Robinhood Markets, Inc.$0 M0.00%
Source: SEC Form 13F holdings reports · as of Sep 30, 2026. Value held and share of the company. All holders are on the company page.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Douglas Quinton Larson | Chief Financial Officer | Oct 2024 |
| Michael A. Gaul | Chief Operating Officer | Oct 2024 |
| Steven A. Lisi | Chairman and CEO | Oct 2024 |
| Amir Quinton Avniel | Chief Business Officer | Jun 2023 |
| Jeff Lynn Myers | Chief Medical Officer | Jun 2023 |
| Avniel Amir | President and Chief Operating Officer | Jun 2019 |
| Beck Douglas | Chief Financial Officer | Jun 2019 |
| Steven Lisi | Chairman and CEO | Jun 2019 |
| Amir A. Avniel | Executive officer | Mar 2018 |
| Hai A. Aviv | Executive officer | Mar 2018 |
| Amir Avniel | Executive officer | Jan 2017 |
| Racheli Vizman | Executive officer | Jan 2017 |
| Erick P. Lucera | Director | Oct 2024 |
| Robert A. Carey | Director | Oct 2024 |
| Ron A. Bentsur | Director | Oct 2024 |
| Steven A. Lisi | Chairman and CEO | Oct 2024 |
| William P. Forbes | Director | Oct 2024 |
| Yoori P. Lee | Director | Oct 2024 |
| Amir Quinton Avniel | Chief Business Officer | Jun 2023 |
| Erick P Lucera | Director | Jun 2023 |
| Robert Lynn Carey | Director | Jun 2023 |
| Ron Lynn Bentsur | Director | Jun 2023 |
| William P Forbes | Director | Jun 2023 |
| Yoori P Lee | Director | Jun 2023 |
| Avniel Amir | President and Chief Operating Officer | Jun 2019 |
| Bentsur Ron | Director | Jun 2019 |
| Carey Robert | Director | Jun 2019 |
| Forbes William | Director | Jun 2019 |
| Lee Yoori | Director | Jun 2019 |
| Lucera Erick | Director | Jun 2019 |
| Steven Lisi | Chairman and CEO | Jun 2019 |
| Amir A. Avniel | Director | Mar 2018 |
| Ari J. Raved | Director | Mar 2018 |
| David A. Grossman | Director | Mar 2018 |
| Erick J. Lucera | Director | Mar 2018 |
| Yoori J. Lee | Director | Mar 2018 |
| Amir Avniel | Director | Jan 2017 |
| Ari Raved | Director | Jan 2017 |
| David Grossman | Director | Jan 2017 |
| Jerome B. Zeldis | Director | Jan 2017 |
Went public since 2018. Its SEC number is that of a company listed on a stock exchange.